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In a previous study [(1984) J. Cell Biol. 98, 7257311 we showed that the level of human MHC, HLA antigens on A431 
carcinoma cells is reduced after these cells bind epidermal growth factor (EGF). Here we use flow cytometry to determine 
the effects of various doses and times of EGF treatment on HLA expression. We then show that the reduction in HLA 
expression is associated with a reduction in the level of phosphorylation of immunoprecipitable surface HLA antigens, 
although longer exposure of cells with EGF increased both surface HLA expression and their phosphorylation levels. 
Lateral diffusion of HLA antigens is lower in EGF-treated than in control cells. The lower diffusion coefficients measured 
may be causally related to the decreased phosphorylation of HLA antigens. 
HLA antigen; EGF receptor; Phosphorylation; Lateral diffusion 
1. INTRODUCTION 
The binding of epidermal growth factor (EGF) 
to specific receptors initiates a number of 
metabolic events. Among these is phosphoryiation 
of tyrosine on the cytoplasmic portion of the 
receptor itself, as well as a number of other mem- 
brane integral and cytoplasmic proteins [2]. Fur- 
ther consequences of EGF binding include 
alterations in activity of other protein kinases [3]. 
Thus EGF binding may alter the phosphorylation 
of many membrane-associated proteins, in turn 
leading to changes in their activity or in their 
metabolism. 
In a previous study on the interrelationship be- 
tween major histocompatibility complex (MHC), 
MHC antigens, HLA antigens of human cells, and 
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the EGF receptor we noted that binding of EGF to 
its receptor effected a reduction of approx. 25% in 
the level of binding of anti-HLA antibodies to the 
cells [ 11. We have investigated some aspects of this 
reduction further and find that EGF binding not 
only alters number of anti-HLA antibodies bound 
to treated cells, but also affects the level of 
phosphorylation of the HLA antigens in these 
cells, and the lateral diffusion of these antigens. 
2. MATERIALS AND METHODS 
2.1. Cells, antibodies and other reagents 
A431 cells were the kind gift of Dr Joseph DeLarco, 
Frederick Cancer Research Center. They were cultured in 
Dulbecco’s modified medium, containing 10% fetal calf serum. 
KE-2, a monoclonal antibody against a monomorphic determi- 
nant of HLA antigens was the gift of Dr Roger Kennett, 
University of Pennsylvania. Its specificity and the preparation 
and labeling of Fab fragments have been described [l]. In the 
experiments described here we used KE-2 Fab labeled with 
5-DTAF [5-(4,6-dichlorotriazinyl)aminofluorescein] (Molecular 
Probes, Eugene, OR), labeled following the manufacturer’s in- 
structions. BBM-l [4], a hybridoma producing monoclonal an- 
tibody to human beta-2 microglobulin, was obtained from the 
American Type Culture Collection, Washington, DC. Epider- 
ma1 growth factor, purified from mouse submaxillary glands by 
the method of Savage and Cohen [5] was the kind gift of Dr 
Akira Komoriya, Meloy Laboratories, Springfield, VA. Phor- 
bol myristate acetate (TPA) was obtained from Sigma Chemical 
co. 
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2.2. EGF treatment of cultured cells and labeling of HLA 
antigens 
One day before treatment, A431 cells were plated at 2.5 x 10’ 
cells per well of a 24-well Falcon plate. After approx. 30 h in- 
cubation EGF was added to the wells to give final concentra- 
tions ranging from 0.15 to 150 nM. Cells were cultured with 
EGF for a further 16-17 h. The same concentrations of EGF 
were added to another set of wells in the plate for 4 h. At the 
end of the incubation with EGF all wells were washed with 
phosphate-buffered saline (PBS), pH 7.4, 0.1% in bovine 
serum albumin (BSA; Sigma) and cells were removed from each 
well with trypsin/EDTA. The suspended cells were washed 
twice with BSA/PBS and labeled with 25,&tube of 
fluorescein-conjugated KE-2 at a final concentration of approx. 
50 gg/ml. After 40 min incubation at O”C, the cells were wash- 
ed 3 times in BSA/PBS and fixed in 1% paraformaldehyde in 
PBS. The concentration and time of incubation were chosen to 
effectively saturate the HLA antigens of A431. 
2.3. Analysis of HLA expression of treated cells 
The labeled cells were examined in a Coulter 752 Flow 
Cytometer, exciting DTAF at 488 nm. Data were collected for 
approx. 25000 cells per sample, using a linear amplifier. The 
linearity of the amplifier was checked with beads conjugated 
with known numbers of fluorescein molecules (Flow Cytometry 
Systems Corp., Research Triangle Park, NC). 
2.4. Radio-phosphate labeling of A431 cells and isolation of 
phosphorylated HLA antigens 
Cells, plated at 2.5 x lo5 per well were grown in the presence 
or absence of EGF before labeling. After washing three times 
in Hepes-buffered isotonic NaCl, 0.1 Vo BSA, the cells were in- 
cubated in 0.5 ml phosphate-free Dulbecco’s modified medium, 
supplemented with 2.4 mg/ml glucose and 1 mg/ml BSA and 
containing 0.1 mCi 32P as sodium phosphate. In one experi- 
ment, the effect of EGF binding on phosphorylation was ex- 
amined by adding EGF at intervals from 0 to 3 h after adding 
sodium [3zP]phosphate. In a second experiment, cells were first 
incubated in EGF for either 4 or 17 h, and then the phosphate 
label was added for 3 h. All incubations were at 37°C in a 5% 
CO2 atmosphere. 
After labeling, the cells were chilled and washed three times 
with cold BSA/PBS. They were then lysed in 1 ml of lysis buf- 
fer (10 mM Tris-HCl, pH 7.4, 100 mM NaCl, 1 mM MgClz, 
0.1% BSA, 10 pg/ml trasylol, 2 mM phepylmethylsulfonyl 
Buoride, 50 mM NaF and 1% NP-40) at 0°C for 20 min and the 
detergent insoluble residue pelleted by centrifugation at 
10000 x g for 20 min. The detergent-soluble supernatant was 
cleared of materials non-specifically binding to protein A by in- 
cubation with 50 ~1 per sample of fixed Staphylococcus aureus 
(Pansorbin, Calbiochem) for 30 min at 4’C, followed by cen- 
trifugation at -1500 x g for 10 min. The cleared supernatant 
was mixed with either KE-2, BBM.1 or goat anti-mouse Ig an- 
tibodies (specificity control), at equivalent concentrations 
together with 100 pl of 10% fixed 5. aureus and incubated for 
2 h at 4°C. The antigen-antibody-S. aureus complexes were 
pelleted by centrifugation at -1500 x g for 10 min, and the 
pellets washed 4 times in NDS buffer (10 mM Tris-HCI, pH 7.4, 
150 mM NaCl, 0.5% NP-40, 0.05% SDS, 0.05% Na- 
deoxycholate). The washed pellets were boiled in sample buffer 
(2% SDS, 10% glycerol, 0.25% 2-mercaptoethanol and 0.25% 
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bromophenol blue in 0.0625 M Tris-HCI buffer, pH 6.8) and 
run on 5-15% acrylamide gels. The gel was first subjected to 
autoradiography to visualize the labeled HLA. Bands were then 
cut from the same gel and their radioactivity determined by li- 
quid scintillation counting. Radioactivity was normalized to 
number of cells per well since long exposure to high concentra- 
tions of EGF inhibits growth of A431 cells. This procedure 
evaluates phosphorylation of all cellular HLA antigens, surface 
and internal. Incorporation of [32P]phosphate into total 
detergent-soluble protein was measured in trichloroacetic acid 
precipitates of cell lysate prepared as described above. 
The phosphorylation of surface HLA antigens was deter- 
mined by adding KE-2 antibody to intact “P-labeled cells 
before lysis. 500~1 of KE-2 (at 250,~g/ml) were added to 
labeled cells that had been washed with BSA/PBS and the mix- 
ture incubated for 2 h at 4°C. In order to suppress exchange of 
antibody with labeled intracellular HLA molecules, the intact 
cells were then mixed with unlabeled cell lysate in BSA/PBS 
(1:4) and incubated for a further 1 h at 4°C. Following this the 
cells were lysed and HLA immunoprecipitated without further 
addition of antibody. 
2.5. Measurement of lateral diffusion of HLA antigens 
Lateral diffusion of HLA antigens was compared in control 
and EGF-treated cells using the method of fluorescence 
recovery after photobleaching [6-81. The instrument used for 
these measurements and the approaches to labeling have been 
described [6,7]. Cells were grown on coverslips and labeled with 
FL-KE-2 Fab for 15 min at 0°C. Diffusion was measured on 10 
to 15 cells for each treatment group, and for the same number 
of cells in each control group. 
3. RESULTS 
The fluorescence of a population of 
Fl -KE-Zlabeled A43 1 cells approximates a normal 
distribution. In control populations, the peak of 
this distribution is approximately at channel 60. 
Under optimum conditions of treatment with 
EGF, 1.5 nM EGF for 4 h, the peak is shifted to 
channel 30. Calibration of the flow cytometer with 
standard fluorescein beads indicates that this shift 
represents a 50% decrease in fluorescent molecules 
bound per cell (fig.1). 
The reduction in HLA binding after 4 h was on- 
ly marked at one concentration of EGF. Concen- 
trations IO-fold less or lo-fold greater had a small 
effect on KE-2 binding after 4 h, while no effect 
was seen if lOO-times the optimum dose, 150 nM 
EGF, was used. The relative response to doses of 
EGF was the same in cells treated for 16- 17 h as 
in cells treated for 4 h. The least KE-2 was bound 
to cells treated with 1.5 nM EGF, while the most 
bound to cells treated with 150 nM EGF. 
However, the absolute levels of KE-2 binding to 
cells treated for 17 h were very different from 
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Fig. 1. Distribution of fluorescence in populations of A43 1 cells 
labeled with fluorescent KE-2, anti-HLA antibodies. Ordinate, 
number of cells; abscissa, relative fluorescence on a scale of 256 
channels. (a) Cells treated with 1.5 nM EGF for 4 h, right-hand 
peak, compared to untreated cells. (b) Cells treated with 
150 nM EGF for 4 h compared to untreated cells. 
those cells treated for 4 h. The depression in KE-2 
binding after 17 h in 1.5 nM EGF was approx. 
one-third that induced by 4 h exposure to this con- 
centration of EGF. Furthermore, 17 h exposure to 
15 or 150 nM EGF resulted in an increase in the 
levels of KE-2 bound to approx. 125% of control 
values (fig.2). As has been reported [9,10], con- 
tinued incubation in EGF inhibited the growth of 
A431 at all concentrations tested. Thus the levels 
of KE-2 bound did not correlate with the extent of 
inhibition of cell growth by EGF. 
EGF may directly or indirectly stimulate 
phosphorylation of membrane proteins. The 
cytoplasmic domain of HLA antigens contains 
several serine residues that may be phosphorylated 
in vivo [ll]; a tyrosine in this domain of purified 
-30 I 1 1 / I 
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109 [EGF, Ml 
Fig.2. Effects of EGF on KE-2 binding to the HLA antigens of 
A431 cells. (0) 4 h treatment with EGF; (0) 17 h treatment 
with EGF; (B) 4 h treatment with 100 ng/ml of phorbol 
myristate acetate (TPA). 
antigen is phosphorylated in vitro by pp60”” [12]. 
We therefore examined the effect of EGF on the 
phosphorylation of HLA antigens precipitated by 
KE-2 or by antibody to the beta-2m light chain. 
Phosphorylated HLA antigens could be specifical- 
ly precipitated from detergent extracts of cells in- 
cubated for l-4 h in [32P]phosphate-containing 
medium. Addition of EGF to cultures reduced the 
i 
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Fig.3. Phosphorylation of specifically precipitated HLA 
antigens after treatment of cells with EGF (0) or with 
100 ng/ml TPA (0). (a) Time course of phosphorylation 
changes. (b) Dose-dependence of phosphorylation changes. 
[“PIPhosphate and various ligands were simultaneously added 
to cells and incubated for the time indicated. 
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Fig.4. Phosphorylation of specifically precipitable HLA 
antigens labeled after incubation of cells with EGF for 4 ( w), or 
16 h (0) followed by washing and addition of “P for 4 h. 
level of precipitable phosphorylated HLA, as a 
function both of time of incubation, and of EGF 
concentration (fig.3a,b). Phorbol myristate 
acetate, which activates protein kinase C [ 131, had 
no effect on HLA phosphorylation, though it had 
a small effect on binding of KE-2 to the cells 
(fig.2). 
A short time (4 h) exposure of A431 cells with 
1.5 or 15 nM EGF significantly reduced the 
phosphorylation of HLA (fig.3). The reduction is 
well correlated with the changes of the level of cell 
surface HLA (fig.2). However, if the phosphoryla- 
tion of HLA was observed after long time treat- 
ment (17 h) of EGF, it was significantly increased; 
the effect was maximum at 15 nM with small in- 
crease even at 1.5 nM (fig.4). These changes again 
well correlated with the changes of surface HLA 
levels (fig.2); a treatment with 15 nM EGF in- 
creased surface HLA whereas 1.5 nM reversed a 
marked decrease seen when cells were treated with 
the hormone for 4 h. The apparent discrepancy 
seen between the data of total surface HLA and 
phosphorylation of HLA after long time-exposure 
Table 1 
Effects of EGF treatments on the level of phosphorylated HLA with A431 cells 
Treatments ‘*P in HLA 32P in trichloro- [A]/[B] 
acetic acid- (%) 
(cpm/band (cpm/band (Vo) insoluble fraction 
per well)’ per lo6 cells) (cpm/well) 
[Al x 1O-6 [B] 
Total HLA 
None 
EGF (4 h)a 
EGF (16 h)b 
Surface HLA 
None 
EGF (4 h)a 
EGF (16 h)b 
1868 1893 (100) 9.33 (100) 
1388 1554 82 8.48 82 
1993 2623 138 6.18 161 
1529 1490 100 6.28 100 
(79)d 
1027 1185 19 6.24 68 
(76) 
1833 2500 168 5.56 135 
(95) 
a Labeling with [3ZP]phosphate for 4 h in the presence of 15 nM EGF 
b Labeling with [“PIphosphate for 4 h after incubation of cells with 15 nM EGF for 
16 h, followed by washing 
’ These values are normalized by the background activity (535 cpm) of the gel 
d Vo of total HLA-associated radioactivity in surface HLA antigens 
After the labeling with [32P]phosphate, phosphorylated HLA antigens were 
immunoprecipitated from either whole cell extracts after lysis (total HLA) or from 
extracts prepared with cells which had been immunoreacted with antibody before lysis 
(membrane bound HLA), and isolated by SDS gel electrophoresis 
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with 1.5 nM EGF may be explained by the fact 
that the total HLA was measured at exactly 17 h 
after the hormone treatment whereas the radioac- 
tive phosphate incorporation took an extra 4 h for 
labeling after 17 h EGF treatment. The effects of 
EGF to stimulate the phosphorylation seem to be 
initiated roughly around 4 h after the addition of 
EGF since the labeling after this period for 4 h 
(fig.4) increased the phosphorylation but the label- 
ing before 4 h in the presence of EGF (fig.3) 
decreased it. 
In control cells, 80% of the 32P incorporated in- 
to HLA antigens was associated with surface HLA 
(table 1, column B). This proportion remained 
roughly the same when the cells were treated with 
EGF for 4 h and increased to 95% after 17 h. It 
can also be seen from table 1 that the ratio of 
specifically precipitable radioactivity (column A) 
to trichloroacetic acid-precipitable radioactivity 
(column B) is not constant. Thus the changes in 
phosphorylation of HLA were not due to changes 
in sizes of metabolic pools affecting all 
phosphoproteins. 
These results suggest that short time treatments 
of A431 cells with EGF evoke the reduction of 
both surface HLA and their phosphorylation 
whereas long time exposures of the cells with the 
hormone increase them. The EGF concentrations 
effective in the reductions and increments seem ap- 
prox. 1.5 nM and 15 nM respectively. 
The lateral diffusion of HLA antigens is con- 
strained in most cells studied presumably by in- 
Table 2 
Effect of EGF on lateral diffusion of HLA antigens in A431 
cells 
Treatment No. D cm’/s (x 10”) 
* SE (& 
Arithmetic Geometric 
None 105 5 ? 0.4 4 + 0.2 61 k 2 
15nMEGF 
4h 46 4 k 0.4 3 + 0.2 54 * 2 
17 h 39 4 + 0.5 3 + 0.2 59 + 2 
1.5 nM EGF 
4h 44 4 + 0.5 3 + 0.2 62 Z!I 2 
17 h 41 4 + 0.4 3 + 0.2 59 * 2 
All diffusion coefficients for HLA antigens in EGF-treated cells 
differ significantly from that for HLA antigens in control cells 
(P < 0.01) 
teractions between the HLA antigens and some 
molecules of the cytoplasm. Phosphorylation 
could regulate such interactions [ 141. Since our 
results indicate that most phosphorylated HLA 
molecules are at the cell surface, it was of interest 
to see if the changes in phosphorylation were cor- 
related with changes in lateral mobility of HLA an- 
tigens. As is the case in other cells, lateral diffusion 
of HLA antigens was approx. l/10 that calculated 
from the molecular mass of the antigens and the 
apparent viscosity of lipid bilayers. About 60% of 
the labeled molecules were mobile in the plane of 
the membrane. Though the mobile fraction of 
HLA antigens in cells treated with EGF did not 
differ significantly from that in controls (table 2), 
the diffusion coefficients of the HLA antigens 
were significantly lower in EGF-treated cells than 
I n 
ti =3.8E-010 
+/-2.9E-010 
Rcv'y= 599, 
PW = 10615 
D =3.6E-010 
+/-2.9E-010 
9cv'y= 54 
Pre = 11716 
,- , 
IInMEGF-16h 
b =3.8E-010 
+I-2.4E-010 
RCV'Y = 59 
PW = 9869 
LInMEGF-16h 
b =3.9E-010 : 
+/-3.6E-010 . _ 
Rcv'y = 61" _ _ 
Pre = ,085, 
4 
l.SnMEGF-4h 
L? =5.2E-010 
+I-3.ai-010 
Rcv'y = 61 
Pre = 9531 
i.OE-011,bar 3.0E-011 Z.lE-00 
Fig.5. Diffusion coefficients measured for HLA antigens on 
control and EGF-treated cells. 
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in controls (table 2). This is also evident in the 
histograms of diffusion coefficients of fig.5. Even 
concentrations of EGF which do not greatly affect 
phosphorylation of total cell HLA do appear to af- 
fect lateral diffusion of the antigens. 
The values for diffusion coefficients are not nor- 
mally distributed. This distribution distorts both 
the mean diffusion coefficients and the standard 
error of these means. Accordingly, in addition to 
the arithmetic means, we also took the geometric 
means of the diffusion coefficients. The log- 
normal distribution upon which these means are 
based has a reduced variance, and, perhaps more 
importantly, down-weights outlying values of D. 
The geometric means of the diffusion coefficients, 
given in table 2, while lower than the arithmetic 
means also differ significantly between control and 
EGF-treated cells. 
4. DISCUSSION 
This report extends our previous observation 
that fewer anti-HLA antibodies bind to EGF- 
treated A431 cells than to control cells [l]. Using 
flow cytometric measurements of fluorescent an- 
tibody binding, we find that the reduction in an- 
tibody binding by prior EGF treatment is at a 
maximum when the concentration of EGF used is 
1.5 nM, which is sufficient to saturate high affinity 
EGF receptors, but that higher concentrations of 
EGF may reverse the effect, or even enhance 
binding of anti-HLA antibodies. The kinetics of 
the effect we observed here are slower than those 
reported earlier [l]. However, we did not use the 
same A43 1 cells and growth and culture conditions 
also were slightly different from those used earlier. 
We have some preliminary evidence (Hosoi and 
Edidin, unpublished) that the kinetics of the reduc- 
tion in KE-2 binding may vary with culture con- 
ditions. 
EGF treatment of A431 cells also reduces 
phosphorylation of specifically precipitable HLA 
antigens, mainly those at the cell surface, in a dose- 
dependent manner. Though a concentration of 
EGF giving maximum inhibition of phosphoryla- 
tion could not be defined in experiments in which 
cells are concurrently given the hormone and 
[32P]phosphate, an optimum dose of EGF was 
defined in experiments in which cells are labeled 
with 32P after incubation with EGF. This experi- 
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ment also makes it evident that the reduction in 
HLA phosphorylation in EGF-treated cells is not 
due to cell damage or death. The optimum concen- 
tration for stimulation of phosphorylation defined 
by it is lo-fold higher than the optimum for sup- 
pression of anti-HLA binding. In both systems lit- 
tle or no effect of EGF is seen if its concentration 
is varied lo-fold higher or lo-fold lower than its 
optimum. 
Recently, Cantrell et al. [15] reported a short- 
term effect of phorbol esters on the phosphoryla- 
tion of HLA antigens and of the Ti/T3 complex of 
T lymphoblasts. The phosphorylation stimulated 
by phorbol esters is associated with a reduction in 
surface levels of T3 antigens, but has no effect on 
the levels of HLA antigens. Feuerstein et al. [16] 
have also reported increases in HLA phosphoryla- 
tion after exposure of cells to phorbol esters. In 
our experiments phorbol myristate acetate treat- 
ment also had little effect on levels of HLA at the 
cell surface and had no effect on HLA 
phosphorylation. However, we examined HLA 
phosphorylation at later times after phorbol ester 
treatment han were used by Cantrell et al. [ 151. 
The site and mechanism of the changes in HLA 
phosphorylation induced by EGF are unclear. The 
long times used in our experiments obscure the im- 
mediate effects of EGF on the cells, and our obser- 
vations could reflect the secondary action of 
kinases, other than the EGF receptor tyrosine 
kinase on the HLA antigens. If one considers the 
observed constancy of a serine phosphorylation 
site on MHC antigens [ll], and the uncertainty 
whether or not the tyrosine of the cytoplasmic 
region is indeed phosphorylated in vivo, it seems 
likely that the HLA molecules are not in fact 
directly labeled by the EGF receptor kinase. We 
also cannot tell if the reductions in phosphoryla- 
tion induced by EGF are due to reduced activity of 
a kinase or to enhanced activities of a 
phosphodiesterase. 
There are several reports [17-191 that the recycl- 
ing of surface receptors for insulin-like growth fac- 
tors and transferrin is affected by the level of 
phosphorylation of the receptors. Reductions in 
receptor phosphorylation lead to longer residence 
times at the cell surface [19] while ‘hyper- 
phosphorylation’ [ 181 seems to be associated with 
enhanced receptor internalization in coated 
vesicles. Unlike these other receptors, HLA an- 
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tigens seem to be marked for internalization by 
dephosphorylation, rather than by phosphoryla- 
tion. However, endocytosis of HLA antigens and 
some other membrane proteins appears to take 
place outside of the usual pathway of coated pits 
and coated vesicles [20-221 (Wier and Edidin, un- 
published). It might be that this rather different 
endocytic cycle uses phosphorylation as a control 
point but in a manner different to that in the cycle 
for transferrin receptors. 
EGF treatment significantly affects the lateral 
diffusion of surface HLA antigens. While the dif- 
ferences in diffusion coefficients between HLA in 
control cells and HLA antigens of cells treated 
with 1.5 or 15 nM EGF are small, they are signifi- 
cant. Other work [23], comparing the lateral diffu- 
sion of mutant MHC antigens completely lacking 
cytoplasmic tails with the lateral diffusion of 
mutants bearing 2-4 cytoplasmic residues, one of 
which is a serine, suggests that dephosphorylation 
of MHC antigens results in smaller diffusion coef- 
ficients, possibly due to the molecules’ aggregation 
[24]. Lateral diffusion coefficients vary as the log 
of the radius of the diffusing particles [25]. 
Therefore, a change of 20-25% in diffusion coef- 
ficient could reflect formation of aggregates of 
several hundred molecules. Since MHC antigens 
appear normally to exist as monomers [26] 
(Edidin, Zidovetski and Jovin, unpublished), ag- 
gregates of this size indicate considerable 
reorganization of the cell surface. The persistence 
of the effect on lateral diffusion at 17 h could 
reflect the persistence of a high proportion of un- 
phosphorylated HLA molecules at the cell surface 
even after newly phosphorylated molecules arrive 
at the surface. 
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